Atricure Inc (ATRC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Atricure Inc Stock (ATRC) Company Profile

Atricure Inc

Healthcare (1161)

513-755-4100

7555 INNOVATION WAY, MASON, OH

Prossima data di guadagno

Ultimi documenti SEC

ATRC's Discussions on Twitter

Confronta ATRC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ATRC Atricure Inc	29.24	1.55B	447.57M	-38.92M	-1.15M	-0.83
ISRG Intuitive Surgical Inc	516.12	185.10B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	175.33	50.76B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	87.16	43.19B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	261.07	37.26B	5.02B	1.31B	1.56B	8.91
WST West Pharmaceutical Services Inc	210.08	16.13B	2.90B	467.20M	306.90M	6.37

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-17	Ripresa	JP Morgan	Overweight
2024-04-23	Aggiornamento	Oppenheimer	Perform → Outperform
2023-10-23	Iniziato	JMP Securities	Mkt Outperform
2023-09-29	Iniziato	UBS	Buy
2021-08-05	Downgrade	Oppenheimer	Outperform → Perform
2020-12-18	Reiterato	Needham	Buy
2020-11-06	Reiterato	Needham	Buy
2020-04-07	Iniziato	Oppenheimer	Outperform
2020-02-06	Iniziato	BTIG Research	Buy
2020-01-24	Reiterato	Needham	Buy
2019-08-13	Downgrade	Northland Capital	Outperform → Market Perform
2019-04-12	Iniziato	JP Morgan	Overweight
2018-10-04	Reiterato	Needham	Buy
2018-08-02	Reiterato	Needham	Buy
2018-08-02	Reiterato	Stifel	Buy
2018-06-18	Reiterato	Needham	Buy
2018-04-27	Reiterato	Needham	Buy
2018-01-16	Reiterato	Needham	Buy
2017-11-02	Reiterato	Needham	Buy
2017-07-28	Reiterato	Needham	Buy
2017-05-30	Ripresa	Piper Jaffray	Overweight
2016-06-30	Ripresa	JMP Securities	Mkt Outperform
2015-10-28	Reiterato	Needham	Buy
2015-10-06	Reiterato	Canaccord Genuity	Buy
2015-10-06	Reiterato	Needham	Buy

Mostra tutto

Atricure Inc Borsa (ATRC) Ultime notizie

Atricure Inc Azioni (ATRC) Dati Finanziari

Atricure Inc (ATRC)

Atricure Inc Stock (ATRC) Company Profile

Confronta ATRC con altri titoli

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Atricure Inc Borsa (ATRC) Ultime notizie

What drives AtriCure Inc. stock priceRapid growth trajectories - Autocar Professional

AtriCure Inc. Stock Analysis and ForecastFree Stock Market Trend Analysis - Autocar Professional

Left Atrial Appendage Closure (LAAC) Device Market Key Players, Share and Forecast Outlook - openPR.com

What analysts say about AtriCure Inc. stockStrong return on assets - jammulinksnews.com

Is AtriCure Inc. a good long term investmentFree High-Return Strategy Alerts - PrintWeekIndia

AtriCure Shares Plunge 1.65% Amid FDA Approval Concerns - AInvest

AtriCure Inc. (ATRC) shares plunge 2.07% to lowest since May 2025 - AInvest

AtriCure Inc. (ATRC) Drops 2.94% in Two Days, Hits 2025 Low - AInvest

AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention - BioSpace

Why AtriCure Inc. stock attracts strong analyst attentionMarket Timing Advice - Newser

Why RadNet Inc. stock attracts strong analyst attentionReal Time Alert Service - Newser

How AtriCure Inc. stock performs during market volatilityFree Predictions - Newser

AtriCure completes enrollment in landmark cardiac stroke prevention trial By Investing.com - Investing.com Canada

AtriCure completes enrollment in landmark cardiac stroke prevention trial - Investing.com Australia

What makes AtriCure Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser

AtriCure, Inc. (ATRC) Stock Analysis: Unveiling a 59% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews

AtriCure completes enrollment in stroke prevention trial - MassDevice

Left Atrial Appendage Closure Devices Market Exclusive Report - openPR.com

(ATRC) On The My Stocks Page - news.stocktradersdaily.com

AtriCure Data Breach Investigation - Claim Depot

Artivion Inc. Data Breach Affects 5,608 in Texas: SSNs Exposed - Claim Depot

AtriCure (NASDAQ:ATRC) Has Debt But No Earnings; Should You Worry? - simplywall.st

AtriCure to Announce Second Quarter 2025 Financial Results - The Globe and Mail

Leading Afib Treatment Innovator AtriCure Announces Q2 2025 Earnings DateKey Details Inside - Stock Titan

AtriCure, Inc. (NASDAQ:ATRC) Receives Consensus Rating of “Buy” from Analysts - Defense World

AtriCure, Inc.(NasdaqGM: ATRC) dropped from Russell 3000E Value Index - MarketScreener

Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year? - Yahoo Finance

AtriCure: Profits And Operating Leverage Are Needed Here (NASDAQ:ATRC) - Seeking Alpha

Cryoablation Probe Market Size, Share | Industry Report 2030 - Grand View Research

Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year? - Yahoo Finance

Transcript : AtriCure, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 04 - MarketScreener

AtriCure at Goldman Sachs Conference: Strategic Growth Insights - Investing.com India

AtriCure at Goldman Sachs Conference: Strategic Growth Insights By Investing.com - Investing.com UK

AtriCure's Strategic Momentum: Leadership in Atrial Fibrillation Management Takes Center Stage - AInvest

Ameriprise Financial Inc. Invests $295,000 in AtriCure, Inc. (NASDAQ:ATRC) - Defense World

Global Cardiac Ablation Market: Advancements in Minimally Invasive Procedures and 13% CAGR by 2030 - PharmiWeb.com

Left Atrial Appendage Closure Device Market projected to surpass US$ 8,786.032 million by 2030 at a CAGR of - EIN News

AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Jane Street Group LLC - Defense World

AtriCure (NASDAQ:ATRC) Downgraded to “Hold” Rating by Wall Street Zen - Defense World

(ATRC) Investment Analysis - news.stocktradersdaily.com

AtriCure’s chief scientific officer sells $83,600 in stock By Investing.com - Investing.com India

Insider Sell: Vinayak Doraiswamy Sells 2,500 Shares of AtriCure Inc (ATRC) - GuruFocus

AtriCure’s chief scientific officer sells $83,600 in stock - Investing.com Australia

Investors push AtriCure (NASDAQ:ATRC) 3.9% lower this week, company's increasing losses might be to blame - simplywall.st

Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Atricure Inc Azioni (ATRC) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a ATRC